Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1956 1
1957 3
1961 3
1962 4
1963 11
1964 5
1965 7
1966 3
1967 8
1968 11
1969 8
1970 8
1971 10
1972 6
1973 2
1974 4
1975 7
1976 10
1977 10
1978 8
1979 3
1980 3
1981 11
1982 16
1983 19
1984 14
1985 18
1986 13
1987 18
1988 13
1989 11
1990 20
1991 20
1992 31
1993 29
1994 31
1995 37
1996 28
1997 22
1998 35
1999 48
2000 62
2001 54
2002 72
2003 74
2004 67
2005 66
2006 79
2007 95
2008 86
2009 66
2010 91
2011 105
2012 120
2013 134
2014 164
2015 188
2016 173
2017 158
2018 186
2019 177
2020 169
2021 209
2022 208
2023 219
2024 214
2025 242
2026 148

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,788 results

Results by year

Filters applied: . Clear all
Page 1
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.
Döhner H, DiNardo CD, Appelbaum FR, Craddock C, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele G, Röllig C, Sierra J, Stein EM, Tallman MS, Tien HF, Wang J, Wierzbowska A, Wei AH, Löwenberg B. Döhner H, et al. Among authors: miyazaki y. Blood. 2024 Nov 21;144(21):2169-2173. doi: 10.1182/blood.2024025409. Blood. 2024. PMID: 39133932 Free article.
IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancer.
Ibusuki R, Iwama E, Shimauchi A, Kawano H, Mizusaki S, Nakamura S, Miyazaki Y, Inutsuka Y, Hashisako M, Harada T, Tsuchiya-Kawano Y, Tsutsumi H, Nakanishi T, Nakagaki N, Koga Y, Kimura S, Mashimoto S, Shibahara D, Otsubo K, Yoneshima Y, Tanaka K, Oda Y, Okamoto I. Ibusuki R, et al. Among authors: miyazaki y. Mol Cancer. 2025 Oct 28;24(1):272. doi: 10.1186/s12943-025-02493-6. Mol Cancer. 2025. PMID: 41152910 Free PMC article.
Human Monkeypox Proctitis.
Miyazaki Y, Adachi T, Kuniyoshi N, Noda Y, Nagashima M. Miyazaki Y, et al. Balkan Med J. 2024 Jul 5;41(4):310-311. doi: 10.4274/balkanmedj.galenos.2024.2024-1-94. Epub 2024 May 21. Balkan Med J. 2024. PMID: 38769742 Free PMC article. No abstract available.
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma.
Cho H, Shiraishi K, Sunami K, Momozawa Y, Yoshida T, Matsumoto S, Matsuda K, Saito M, Goto A, Honda T, Mochizuki A, Torasawa M, Daigo Y, Shimizu K, Kunitoh H, Yoshida Y, Hirata M, Shimada Y, Ueki M, Ono H, Gotoh M, Shimoda Igawa Y, Tateishi A, Yamaguchi Y, Inaba Higashiyama R, Machida E, Iwasaki M, Kawai Y, Yasuda H, Hamamoto J, Imoto I, Matsushita H, Takata S, Aoi T, Kaneko S, Kuchiba A, Shimomura A, Fukami M, Hattori K, Ozaki K, Asano Y; NCBN Controls WGS Consortium; Biobank Japan Project; Takano A, Kobayashi M, Miyagi Y, Tanaka K, Suzuki H, Yamaura T, Yoshida T, Goto Y, Horinouchi H, Miyazaki Y, Ito H, Nagashima T, Ohtaki Y, Imai K, Minamiya Y, Okubo K, Inazawa J, Shiraishi Y, Tokunaga K, Kamatani Y, Yatabe Y, Goto K, Tsuboi M, Watanabe SI, Ohe Y, Murakami Y, Matsuo K, Hamamoto R, Kohno T. Cho H, et al. Among authors: miyazaki y. J Thorac Oncol. 2025 Nov;20(11):1626-1638. doi: 10.1016/j.jtho.2025.06.005. Epub 2025 Jun 15. J Thorac Oncol. 2025. PMID: 40516820 Free article.
Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo S, Miyazaki Y, Nishino T, Fujita Y, Kono M, Kawashima T, Ishigaki K, Kusaka K, Tanaka H, Ueno M, Satoh-Kanda Y, Inoue Y, Todoroki Y, Miyagawa I, Hanami K, Nakayamada S, Tanaka Y. Kubo S, et al. Among authors: miyazaki y. Ann Rheum Dis. 2025 Feb;84(2):210-220. doi: 10.1136/ard-2024-226228. Epub 2025 Jan 2. Ann Rheum Dis. 2025. PMID: 39919895
P2Y12 Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRAS.
Fujimoto S, Iguchi Y, Yamagami H, Koga M, Itabashi R, Yakushiji Y, Kowata K, Kimura N, Terasawa Y, Shimizu T, Miyazaki Y, Oki K, Masuo O, Matsuoka H, Arakawa S, Ueda T, Tanaka R, Hashimoto W, Abe S, Kato G, Furugori T, Kimura K; ACUTE-PRAS Investigators. Fujimoto S, et al. Among authors: miyazaki y. Circ J. 2025 Nov 25;89(12):1922-1930. doi: 10.1253/circj.CJ-24-0949. Epub 2025 May 16. Circ J. 2025. PMID: 40383626 Free article. Clinical Trial.
3,788 results